Form 4: CalciMedica's Chief Business Officer, Eric W. Roberts, Increases Stake in Company

Eric W. Roberts, Chief Business Officer of CalciMedica, recently acquired 5,000 shares of common stock at $3.22 per share, increasing his total holdings.

Summary

• On June 27, 2024, Eric W. Roberts, the Chief Business Officer of CalciMedica, purchased 5,000 shares of the company's common stock at a price of $3.22 per share.
• Following this transaction, Roberts directly owns 111,373 shares of CalciMedica common stock.
• Roberts also has indirect ownership through various entities, including FMTC Custodian Roth IRA FBO Eric W. Roberts (10,223 shares), Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA (39,894 shares), IRA Financial Trust Company CFBO Eric W. Roberts (10,661 shares), Valence Investments SPV IV, LLC (356,989 shares), Valence Investments SPV V, LLC (66,228 shares), and Valence Investments SPV VI, LLC (316,109 shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but without additional context, it's difficult to gauge the overall impact.

Positives

• The purchase of shares by a company officer can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure required by the SEC when company insiders trade in their own company's stock. It provides transparency to the market about the actions of key personnel.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates